Fourth Circuit Nixes Patient Assistance Charity’s Challenge to Unfavorable OIG Advisory Opinion
- January 24, 2025
A nonprofit seeking to offer cost-sharing subsidizes to Medicare Part D beneficiaries for pricey oncology medications that are funded by the pharmaceutical companies that manufacture those drugs failed to revive its challenge to an unfavorable advisory opinion issued by the Department of Health and Human Services (HHS) Office of Inspector General (OIG) after the Fourth Circuit affirmed January 23 a lower court decision rejecting the action.
ARTICLE TAGS
You must be logged in to access this content.